Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KINS is a Japanese microbiome-focused health and beauty company that leverages genomic data to provide personalized skincare and wellness solutions. The company offers microbiome testing kits for the skin, gut, and vagina, using the results to recommend specific probiotic supplements and skincare products. By maintaining a large database of microbiome samples, KINS aims to develop therapeutic solutions for chronic conditions like acne and dermatitis. Their business model integrates diagnostics with consumer products to optimize the symbiotic relationship between humans and their resident microbes. The company also operates specialized clinics and has expanded into the veterinary market with microbiome products for pets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KINS.